Lattice Biologics Ltd. Lattice Biologics Ltd.

Lattice Biologics Ltd.

LBLTF

Rank in Stocks #34360
Lattice Biologics Ltd. is a biotechnology firm focused on developing,... Lattice Biologics Ltd. is a biotechnology firm focused on developing, manufacturing, and commercializing biological products designed for bone regeneration. These solutions are utilized globally across dental, spinal, and general orthopedic indications. The company's innovative offerings include novel amniotic fluid-based therapies such as AmnioBoost and AmnioBlast. In addition, their product line features a broad range of allografts, encompassing traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix varieties. These versatile products serve numerous critical medical applications, from enhancing spinal fusion and aiding breast reconstruction post-mastectomy to promoting bone regeneration in foot and ankle surgeries and fostering skull healing after neurosurgery. They also play a role in improving wound repair for burn victims, facilitating hernia repair, addressing subchondral bone defects in knee and other joint surgeries, and supporting various sports medicine procedures, including anterior and posterior cruciate ligament repairs. The company's headquarters are located in Belgrade, Montana.
Share Price
$0.0001
Last synced: 2026-11-19
Market Cap
$12.82K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Lattice Biologics Ltd. (LBLTF)
Operating Margin as of November 2026 TTM: -13.64%
According to Lattice Biologics Ltd.'s latest financial reports, its current operating margin (TTM) is -13.64%. At the end of 2020 the company had an operating margin of -13.64%.
Operating Margin history for Lattice Biologics Ltd. from 2001 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -13.64% 0.00%
2020 -13.64% -47.15%
2019 -25.81% -77.57%
2018 -115.06% 21.68%
2017 -94.56% 3.55%
2016 -91.32% 45.34%
2015 -62.83% -97.67%
2014 -2,699.17% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% 0.00%
2003 0.00% 0.00%
2002 0.00% 0.00%
2001 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
15.00% -101.10%
US
18.08% -101.33%
IE
21.25% -101.56%
US
21.05% -101.54%
US
25.52% -101.87%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Lattice Biologics Ltd.'s operating margin

What is Lattice Biologics Ltd.'s operating margin?

Lattice Biologics Ltd.'s operating margin is -13.64%, as of Nov 2026.

What was Lattice Biologics Ltd.'s operating margin in 2020?

In 2020, Lattice Biologics Ltd.'s operating margin was -13.64%, compared with -25.81% in 2019.

How has Lattice Biologics Ltd.'s operating margin changed since 2015?

From 2015 to 2020, Lattice Biologics Ltd.'s operating margin was highest in 2020 (-13.64%) and lowest in 2018 (-115.06%).

How does Lattice Biologics Ltd.'s operating margin compare with similar companies?

Lattice Biologics Ltd.'s operating margin (-13.64%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 25.52%.